We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MS icon
101
Morgan Stanley
MS
$339B
$185M 0.22%
2,180,545
+334,418
+18% +$28.5M
HSIC icon
102
Henry Schein
HSIC
$10B
$185M 0.22%
2,309,071
-125,794
-5% -$9.52M
SLB icon
103
SLB Ltd
SLB
$70.3B
$185M 0.22%
3,454,130
-93,826
-3% -$4.67M
APH icon
104
Amphenol
APH
$186B
$184M 0.22%
4,833,186
-740,272
-13% -$28M
SIGI icon
105
Selective Insurance
SIGI
$5.78B
$184M 0.22%
2,073,088
-481,808
-19% -$43.9M
SPGI icon
106
S&P Global
SPGI
$133B
$182M 0.22%
543,482
+21,550
+4% +$7.1M
WERN icon
107
Werner Enterprises
WERN
$2.76B
$180M 0.21%
4,463,978
+112,591
+3% +$4.59M
TEL icon
108
TE Connectivity
TEL
$59.3B
$179M 0.21%
1,563,465
-70,146
-4% -$8.33M
BKH icon
109
Black Hills Corp
BKH
$5.68B
$179M 0.21%
2,545,637
-55,140
-2% -$3.71M
TER icon
110
Teradyne
TER
$50.5B
$178M 0.21%
2,038,523
+19,410
+1% +$1.66M
KMB icon
111
Kimberly-Clark
KMB
$36B
$176M 0.21%
1,293,190
-61,301
-5% -$7.79M
KBR icon
112
KBR
KBR
$4.45B
$175M 0.21%
3,317,514
-158,945
-5% -$7.91M
FLEX icon
113
Flex
FLEX
$43.7B
$174M 0.21%
10,769,647
+550,542
+5% +$8.26M
SYY icon
114
Sysco
SYY
$39.1B
$173M 0.2%
2,267,760
-112,589
-5% -$9.1M
REGN icon
115
Regeneron Pharmaceuticals
REGN
$70.9B
$173M 0.2%
239,686
-18,887
-7% -$13.9M
MTN icon
116
Vail Resorts
MTN
$5.27B
$173M 0.2%
724,725
+56,361
+8% +$13.2M
PAYC icon
117
Paycom
PAYC
$6.9B
$172M 0.2%
555,355
+20,499
+4% +$6.61M
EW icon
118
Edwards Lifesciences
EW
$49.4B
$171M 0.2%
2,292,238
+208,090
+10% +$16M
NKE icon
119
Nike
NKE
$64.9B
$171M 0.2%
1,460,249
+62,984
+5% +$6.34M
LIN icon
120
Linde
LIN
$237B
$169M 0.2%
517,163
+20,591
+4% +$6.45M
FNB icon
121
FNB Corp
FNB
$6.82B
$168M 0.2%
12,844,538
+861,137
+7% +$11.5M
SHOO icon
122
Steven Madden
SHOO
$3.17B
$166M 0.2%
5,204,183
+320,299
+7% +$10M
HEI.A icon
123
HEICO Corp Class A
HEI.A
$34.9B
$166M 0.2%
1,386,812
+28,117
+2% +$3.43M
NFLX icon
124
Netflix
NFLX
$290B
$166M 0.2%
5,636,270
-607,190
-10% -$17M
BAC icon
125
Bank of America
BAC
$430B
$162M 0.19%
4,897,562
+215,475
+5% +$7.42M

Similar funds

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.